Evidence map›Paper›PMID 32007524›Full record

ArticleThe Journal of infection2020

Emergence of SARS-like coronavirus poses new challenge in China.

Ruichen Wang, Xu Zhang, David M Irwin, Yongyi Shen

Abstract readLetter
In one paragraph

Article in The Journal of infection, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Impact of COVID-19 on Tuberculosis Control.Archivos de bronconeumologia · 2021
    Article
  10. Fine-Scale Space-Time Cluster Detection of COVID-19 in Mainland China Using Retrospective Analysis.International journal of environmental research and public health · 2021
    Article
  11. Characteristics of SARS-CoV-2 and COVID-19.Nature reviews. Microbiology · 2021
    Review
  12. Clinical manifestation and disease progression in COVID-19 infection.Journal of the Chinese Medical Association : JCMA · 2021
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Overview of coronavirus disease 2019: Treatment updates and advances.Journal of the Chinese Medical Association : JCMA · 2020
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Ruichen WangCollege of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
Xu ZhangCollege of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
David M IrwinDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto M5S 1A8, Canada; Banting and Best Diabetes Centre, University of Toronto, Toronto M5S 1A8, Canada.
Yongyi ShenCollege of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China; Key Laboratory of Zoonosis Prevention and Control of Guangdong Province, Guangzhou 510642, China. Electronic address: shenyy@scau.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BetacoronavirusChinaCommunicable Diseases, EmergingCoronavirus InfectionsCOVID-19FemaleHumansMaleMiddle East Respiratory Syndrome CoronavirusPandemicsPneumonia, ViralSARS-CoV-2Severe Acute Respiratory SyndromeSevere acute respiratory syndrome-related coronavirus

Identifiers

PMID32007524
PMCPMC7126811

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.